• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中PARK16基因座的精细定位与重测序

Fine mapping and resequencing of the PARK16 locus in Parkinson's disease.

作者信息

Pihlstrøm Lasse, Rengmark Aina, Bjørnarå Kari Anne, Dizdar Nil, Fardell Camilla, Forsgren Lars, Holmberg Björn, Larsen Jan Petter, Linder Jan, Nissbrandt Hans, Tysnes Ole-Bjørn, Dietrichs Espen, Toft Mathias

机构信息

1] Department of Neurology, Oslo University Hospital, Oslo, Norway [2] University of Oslo, Institute of Clinical Medicine, Oslo, Norway.

Department of Neurology, Oslo University Hospital, Oslo, Norway.

出版信息

J Hum Genet. 2015 Jul;60(7):357-62. doi: 10.1038/jhg.2015.34. Epub 2015 Apr 9.

DOI:10.1038/jhg.2015.34
PMID:25855069
Abstract

The PARK16 locus, spanning five genes on chromosome 1, was among the first genetic regions to show genome-wide association in Parkinson's disease (PD). Subsequent investigations have found variability in PARK16 top-hits and association patterns across populations, and the implicated genes and mechanisms are currently unclear. In the present study, we aimed to explore the contribution of PARK16 variability to PD risk in a Scandinavian population. We genotyped 17 single-nucleotide polymorphisms in a case-control sample set of 2570 individuals from Norway and Sweden to fine map the locus. Targeted resequencing of the full coding regions of SLC45A3, NUCKS1, RAB7L1, SLC41A1 and PM20D1 was performed in DNA pools from a subset of 387 patient samples. We find evidence for an association with PD for rs1775143 as well as a haplotype located around the 5' region of RAB7L1, implicating variants which are not in high linkage disequilibrium with the strongest signal from a recent large meta-analysis in Caucasians. We also provide suggestive support for epistasis between RAB7L1 and LRRK2 as previously hypothesized by others. Comparing our results with previous work, allelic heterogeneity at PARK16 appears likely, and further studies are warranted to disentangle the complex patterns of association and pinpoint the functionally relevant variants.

摘要

位于1号染色体上跨越五个基因的PARK16基因座,是最早在帕金森病(PD)中显示全基因组关联的遗传区域之一。后续研究发现,PARK16的顶级关联信号和关联模式在不同人群中存在差异,目前尚不清楚其中涉及的基因和机制。在本研究中,我们旨在探讨PARK16基因变异对斯堪的纳维亚人群患PD风险的影响。我们对来自挪威和瑞典的2570名个体的病例对照样本集中的17个单核苷酸多态性进行了基因分型,以精细定位该基因座。对387例患者样本子集的DNA池进行了SLC45A3、NUCKS1、RAB7L1、SLC41A1和PM20D1全编码区的靶向重测序。我们发现rs1775143以及位于RAB7L1 5'区域附近的一个单倍型与PD存在关联,这些变异与最近一项针对高加索人的大型荟萃分析中最强信号的连锁不平衡程度不高。我们还为RAB7L1和LRRK2之间的上位性提供了提示性支持,这是其他人之前所假设的。将我们的结果与之前的研究进行比较,PARK16处的等位基因异质性似乎很可能存在,有必要进行进一步研究以理清复杂的关联模式并确定功能相关的变异。

相似文献

1
Fine mapping and resequencing of the PARK16 locus in Parkinson's disease.帕金森病中PARK16基因座的精细定位与重测序
J Hum Genet. 2015 Jul;60(7):357-62. doi: 10.1038/jhg.2015.34. Epub 2015 Apr 9.
2
Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk.RAB7L1假定启动子中的序列改变与帕金森病风险降低的关联。
Arch Neurol. 2012 Jan;69(1):105-10. doi: 10.1001/archneurol.2011.924.
3
RAB7L1 promoter polymorphism and risk of Parkinson's disease; a case-control study.RAB7L1启动子多态性与帕金森病风险:一项病例对照研究。
Neurol Res. 2017 May;39(5):468-471. doi: 10.1080/01616412.2017.1297558. Epub 2017 Feb 28.
4
Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.评估LRRK2与PARK16基因座之间的相互作用对帕金森病风险的影响:一项大型多中心研究分析
Neurobiol Aging. 2017 Jan;49:217.e1-217.e4. doi: 10.1016/j.neurobiolaging.2016.09.022. Epub 2016 Oct 6.
5
Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.阿尔茨海默病和帕金森病全基因组关联研究的主要发现与韩国人群帕金森病发病风险的关联
Neurobiol Aging. 2013 Nov;34(11):2695.e1-7. doi: 10.1016/j.neurobiolaging.2013.05.022. Epub 2013 Jun 29.
6
Association between PARK16 and Parkinson's disease: A meta-analysis.PARK16与帕金森病之间的关联:一项荟萃分析。
Neurosci Lett. 2017 Sep 14;657:179-188. doi: 10.1016/j.neulet.2017.08.022. Epub 2017 Aug 12.
7
RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.RAB7L1 与 LRRK2 相互作用,改变神经元内蛋白质的分拣,从而影响帕金森病的发病风险。
Neuron. 2013 Feb 6;77(3):425-39. doi: 10.1016/j.neuron.2012.11.033.
8
Association of three candidate genetic variants in RAB7L1/NUCKS1, MCCC1 and STK39 with sporadic Parkinson's disease in Han Chinese.RAB7L1/NUCKS1、MCCC1和STK39基因中三个候选基因变异与汉族散发性帕金森病的关联
J Neural Transm (Vienna). 2016 Apr;123(4):425-30. doi: 10.1007/s00702-016-1526-5. Epub 2016 Feb 25.
9
Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.帕金森病中五个孟德尔基因及全基因组关联研究中顶级基因的重测序分析。
Mol Neurodegener. 2016 Apr 19;11:29. doi: 10.1186/s13024-016-0097-0.
10
Patterns of linkage disequilibrium of LRRK2 across different races: implications for genetic association studies.LRRK2 连锁不平衡模式在不同种族中的差异:对遗传关联研究的影响。
PLoS One. 2013 Sep 5;8(9):e75041. doi: 10.1371/journal.pone.0075041. eCollection 2013.

引用本文的文献

1
Bidirectional shifts in Pm20d1 expression impact thermogenesis and metabolism.Pm20d1表达的双向变化影响产热和新陈代谢。
Mol Med. 2025 Aug 28;31(1):283. doi: 10.1186/s10020-025-01345-9.
2
Recent advances in targeting LRRK2 for Parkinson's disease treatment.针对帕金森病治疗靶向亮氨酸丰富重复激酶2(LRRK2)的最新进展。
J Transl Med. 2025 Jul 8;23(1):754. doi: 10.1186/s12967-025-06354-0.
3
The PM20D1-NADA pathway protects against Parkinson's disease.PM20D1-NADA 通路对帕金森病有保护作用。

本文引用的文献

1
Genetic variability in the regulation of gene expression in ten regions of the human brain.人类大脑十个区域中基因表达调控的遗传变异性。
Nat Neurosci. 2014 Oct;17(10):1418-1428. doi: 10.1038/nn.3801. Epub 2014 Aug 31.
2
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.全基因组关联数据的大规模荟萃分析确定了帕金森病的六个新风险位点。
Nat Genet. 2014 Sep;46(9):989-93. doi: 10.1038/ng.3043. Epub 2014 Jul 27.
3
Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes.
Cell Death Differ. 2024 Nov;31(11):1545-1560. doi: 10.1038/s41418-024-01356-9. Epub 2024 Aug 22.
4
The Role of Magnesium in Parkinson's Disease: Status Quo and Implications for Future Research.镁在帕金森病中的作用:现状及对未来研究的启示。
Int J Mol Sci. 2024 Aug 1;25(15):8425. doi: 10.3390/ijms25158425.
5
An Update on the Interplay between LRRK2, Rab GTPases and Parkinson's Disease.LRRK2、Rab GTPases 与帕金森病相互作用的最新研究进展。
Biomolecules. 2023 Nov 13;13(11):1645. doi: 10.3390/biom13111645.
6
Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson's Disease.帕金森病相关抑郁的分子病理生理学的遗传学研究进展。
Medicina (Kaunas). 2023 Jun 13;59(6):1138. doi: 10.3390/medicina59061138.
7
NUCKS1 is a highly modified, chromatin-associated protein involved in a diverse set of biological and pathophysiological processes.NUCKS1 是一种高度修饰的染色质相关蛋白,参与多种生物学和病理生理学过程。
Biochem J. 2022 Jun 17;479(11):1205-1220. doi: 10.1042/BCJ20220075.
8
Alzheimer's Disease-Associated SNP rs708727 in May Increase Risk for Parkinson's Disease: Report from Enlarged Slovak Study.阿尔茨海默病相关 SNP rs708727 可能增加帕金森病发病风险:来自扩大的斯洛伐克研究的报告。
Int J Mol Sci. 2022 Jan 29;23(3):1604. doi: 10.3390/ijms23031604.
9
Mendelian Randomization Analysis Identified Potential Genes Pleiotropically Associated with Polycystic Ovary Syndrome.孟德尔随机化分析鉴定了与多囊卵巢综合征潜在关联的多效性基因。
Reprod Sci. 2022 Mar;29(3):1028-1037. doi: 10.1007/s43032-021-00776-z. Epub 2021 Oct 26.
10
Rab GTPases in Parkinson's disease: a primer.帕金森病中的 Rab GTPases:概述。
Essays Biochem. 2021 Dec 22;65(7):961-974. doi: 10.1042/EBC20210016.
自身免疫和神经退行性疾病风险等位基因在白细胞中的极化效应。
Science. 2014 May 2;344(6183):519-23. doi: 10.1126/science.1249547.
4
Effective variant detection by targeted deep sequencing of DNA pools: an example from Parkinson's disease.通过对DNA池进行靶向深度测序实现有效的变异检测:以帕金森病为例。
Ann Hum Genet. 2014 May;78(3):243-52. doi: 10.1111/ahg.12060. Epub 2014 Mar 24.
5
Association analysis of PARK16-18 variants and Parkinson's disease in a Chinese population.中国人群中 PARK16-18 变异与帕金森病的关联分析。
J Clin Neurosci. 2014 Jun;21(6):1029-32. doi: 10.1016/j.jocn.2013.09.015. Epub 2013 Nov 14.
6
GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16.帕金森病中的全基因组关联研究风险因素:富亮氨酸重复激酶2编码变异及与PARK16的基因相互作用
Am J Neurodegener Dis. 2013 Nov 29;2(4):287-99. eCollection 2013.
7
Substitution p.A350V in Na⁺/Mg²⁺ exchanger SLC41A1, potentially associated with Parkinson's disease, is a gain-of-function mutation.SLC41A1 中的 Na⁺/Mg²⁺ 交换蛋白 A350V 替代突变,可能与帕金森病相关,是一种获得性功能突变。
PLoS One. 2013 Aug 15;8(8):e71096. doi: 10.1371/journal.pone.0071096. eCollection 2013.
8
RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.RAB7L1 与 LRRK2 相互作用,改变神经元内蛋白质的分拣,从而影响帕金森病的发病风险。
Neuron. 2013 Feb 6;77(3):425-39. doi: 10.1016/j.neuron.2012.11.033.
9
Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease.支持帕金森病全基因组关联研究中 11 个位点的证据。
Neurobiol Aging. 2013 Jun;34(6):1708.e7-13. doi: 10.1016/j.neurobiolaging.2012.10.019. Epub 2012 Nov 13.
10
Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants.LRRK2 G2385R 和 R1628P 的外显率受常见 PD 相关遗传变异的影响。
Parkinsonism Relat Disord. 2012 Sep;18(8):958-63. doi: 10.1016/j.parkreldis.2012.05.003. Epub 2012 Jun 2.